The NIH Office of Strategic Coordination (Common Fund - https://commonfund.nih.gov/) has generated several valuable and widely available datasets. The purpose of this Notice is to announce the availability of administrative supplements to existing NIH awards to demonstrate usage of these datasets. This includes generating hypotheses, catalyzing discoveries, and guiding translational/clinical studies.
Administrative supplements must support work within the scope of the parent project. To be eligible for consideration through this NOSI, the proposed research plan must substantially leverage data from at least one Common Fund program listed in the Background section above. “Substantial leverage” is defined as the use and citation of the relevant dataset(s) in the envisioned research products of the proposed work (e.g., manuscripts, presentations, book chapters, portals, etc.) While incorporating data from a single CF program is required, the use of data from two or more multiple Common Fund programs is highly encouraged to build on the goals of the Common Fund Data Ecosystem, which promotes novel discovery through the use of cross-CF study data. Likewise, the utility of the data is enhanced when existing Common Fund data is integrated with other non-CF and CF data sets. Thus, data from other publicly available datasets, including Common Fund programs not listed above, can also be included as needed. Because information regarding the user experience could help NIH improve its data resources, successful applicants will be asked to provide feedback on the findability, usability, and utility of the relevant datasets and public data portals. They may also be afforded an opportunity to present their work at an NIH-sponsored meeting (either virtually or in-person). Beyond that, there are no explicit requirements for how the data are to be used – investigators are encouraged to employ approaches best suited to achieving their parent award’s research aims.
Application Due Date(s) – applications must be submitted on or before June 30, 2023.